Published in Cancer Weekly, February 14th, 2006
"Prostasomes are postulated to be shed into the blood circulation in prostate cancer patients, where they may cause all immune response. An antiprostasome antibody ELISA was developed and used to measure serum antibody titres in 81 males with prostate cancer or benign prostate hyperplasia. Patients with biopsy-verified prostate cancer had significantly higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.